UBE2I and cancer: Expression of key components of the SUMO machinery (such as SUMO1 E1 activating enzyme, E2 conjugation enzyme Ubc9 and some PIAS SUMO E3 ligases) is enhanced in many human cancers, and it correlates with poor prognosis [48].